Attn: President Stock Exchange of Thailand Demeter Corporation Public Company Limited (“DCORP” or the “Company”) would like to submit the reviewed financial statements for first quarter of the year 2020
consolidated financial statements for the three-month period ended 30 June 2019 and 2020 Revenues Q2/63 % Q2/62 % Change +/(-) Revenue from hotel operations 34 6% 279 69% (88%) Revenue from property development
transaction based on the criteria under the Notifications on Acquisition or Disposal of Assets and based upon the 3-month interim consolidated financial statements ended 31 March 2020 of the Company, reviewed
, comprising of selling expenses of 1,075 Million Baht, administrative expenses of 1,466.1 Million Baht and also other expenses of 12.6 Million Baht. PAGE INDEX Executive Summary Financial Summary 2017
Company’s reviewed consolidated financial statements for the 3-month period as of 31 March 2018. When combining with the transactions of disposal of asset during the period of six months prior to the date on
@kkpfg.com Tel. +66-2495-1366 Website: www.kkpfg.com http://www.kiatnakin.co.th/ 2 Change of Company Name From 17 August 2020 onwards, Kiatnakin Phatra Financial Group (KKP) has changed the name for the Bank
considered as a normal level for the business at the beginning stage launching new products into the market which requires high spending. 4. Financial Position of the Company and its Subsidiaries (Unit: Baht
Bt33,822mn of cash CAPEX to enhance 4G capacity and increase fixed broadband last miles. Following the government’s announcement of tax incentive program, AIS recognized a YTD tax benefit in 3Q17 amounting
Osotspa Public Company Limited Q4’18 and FY18 Management Discussion & Analysis 27 February 2019 Q4’18 and 2018 Management Discussion & Analysis Page 1/7 Financial Highlights - Q4’18 Net profit* was
. 1Q21 Financial Summary Revenue For 1Q21, AIS reported a total revenue of Bt45,861mn, increasing 7%YoY from higher handset sales offset by lower core service revenue with continued impact from COVID-19